✦ LIBER ✦

New technologies for vaccine development

✍ Scribed by Kellathur N. Srinivasan; Vladimir Brusic; Thomas J. August

Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 116 KB
Volume: 62
Category: Article
ISSN: 0272-4391
DOI: 10.1002/ddr.10393

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Vaccines offer protection against infectious diseases, but the successes from the years of development have been mixed. Some diseases have been effectively controlled or eradicated through vaccination, whereas treatments for a number of diseases, especially the reemerging diseases, currently do not exist. Improved understanding of pathogen variability as well as of the diversity of the human immune system, plus technological advances in genetic and molecular biology provide better insights in the host–pathogen interaction and new avenues for vaccine development. In this article we discuss the latest trends in vaccine research with focus on epitope‐based DNA vaccines and trafficking components for efficient vaccine delivery. These approaches are promising in dealing with host and pathogen diversity as well as with diversity within human populations. Drug Dev. Res. 62:383–392, 2004. © 2004 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Parasite annexins – New molecules with p

Parasite annexins – New molecules with potential for drug and vaccine development

✍ Andreas Hofmann; Asiah Osman; Chiuan Yee Leow; Patrick Driguez; Donald P. McManu 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 337 KB

New Developments in Fluidization Technol

New Developments in Fluidization Technology

✍ Stefan Heinrich; Joachim Werther 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB 👁 1 views

New technologies for chemical genetics

✍ Leslie A. Walling; Noël R. Peters; Edward J. Horn; Randall W. King 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 290 KB

Chemical genetics, in which small molecules are used in lieu of mutations to study biological processes, requires large and diverse chemical libraries to speci®cally perturb different biological pathways. Here we describe a suite of technologies that enable chemical libraries prepared by split-pool

New technologies for amperometric biosen

New technologies for amperometric biosensors

✍ Martyn G. Boutelle; H. Allen; O. Hill; Manfred Berners; R. John; P. D. Dobson; P 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 761 KB

Amperomeric-based detectors have successfully been used as personal monitors for blood glucose levels. However, there is a desire to increase the number of compounds measured in a small blood sample, the speed of detection and enhance the reliability of the measurement. Furthermore, with the increa

New Findings in Live, Attenuated Hepatit

New Findings in Live, Attenuated Hepatitis A Vaccine Development

✍ P. J. Provost; R. J. Gerety; M. R. Hilleman; W. J. McAleer; E. M. Scolnick; R. P 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 720 KB

Strain CR326F of hepatitis A virus, derived from a fecal specimen of Costa Rican patient 033-03, was passed 15 times in fetal rhesus monkey kidney (FRhK6) cell cultures plus eight times in human diploid lung (MRC5) cell cultures to yield variant F and 16 times in MRC5 cell cultures to yield variant

A lentiviral vector pseudotype suitable

A lentiviral vector pseudotype suitable for vaccine development

✍ Luciene Lopes; Marie Dewannieux; Yasuhiro Takeuchi; Mary K. Collins 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB

## Abstract ## Background Lentiviral vectors (LV) are promising vaccines because they transduce dendritic cells (DC) __in vivo__. To translate LV vaccines into clinical trials, bulk production will be necessary. The present study aimed to find a suitable envelope for LV vaccine production from sta